[3-Methylether-ethinylestradiol (Mestranol) and 6-dehydro-16-methylene-17-alpha-acetoxyprogesterone (Superlutin) in the therapy of functional bleedings].
D000328:Adult; D004357:Drug Synergism; D004717:Endometrium / Q000187:drug effects; D004848:Epithelium / Q000187:drug effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D008796:Metrorrhagia / Q000188:drug therapy*; D008875:Middle Aged; D011374:Progesterone / Q000627:therapeutic use*; D014621:Vagina
D011374:Progesterone; D008656:Mestranol
3-Methyläther-äthinylöstradiol (Mestranol) und 6-Dehydro-16-methylen-17 alpha-acetoxyprogesteron (Superlutin) in der Therapie von funktionellen Blutungen.